1.14.18.6: 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase
This is an abbreviated version!
For detailed information about 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase, go to the full flat file.
Word Map on EC 1.14.18.6
-
1.14.18.6
-
paraplegia
-
sphingolipids
-
2-hydroxylation
-
leukodystrophy
-
nbias
-
atp13a2
-
dystonia
-
pla2g6
-
paraparesis
-
galactosylceramide
-
sulfatide
-
alpha-hydroxylation
-
paucimobilis
-
hydroxylase-associated
-
medicine
- 1.14.18.6
- paraplegia
- sphingolipids
-
2-hydroxylation
- leukodystrophy
- nbias
-
atp13a2
- dystonia
- pla2g6
- paraparesis
- galactosylceramide
- sulfatide
-
alpha-hydroxylation
- paucimobilis
-
hydroxylase-associated
- medicine
Reaction
+ 2 ferrocytochrome b5 + + 2 H+ = + 2 ferricytochrome b5 +
Synonyms
FA2H, AtFAH1, FA2H, FAH1, fatty acid 2-hydroxylase, fatty acid 2-hydroxylase 1, fatty acid alpha-hydroxylase, SCS7, Scs7p, scScs7p, sphingolipid alpha-hydroxylase
ECTree
Advanced search results
Cofactor
Cofactor on EC 1.14.18.6 - 4-hydroxysphinganine ceramide fatty acyl 2-hydroxylase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
cytochrome b5
expression of the FAH1 cytochrome b5 domain in Escherichia coli produces a soluble protein that exhibits the typical oxidized versus reduced differential absorbance spectra of cytochrome b5
-
cytochrome b5
protein contains a cytochrome b5-like domain and a domain that resembles the family of cytochrome b5-dependent enzymes that use iron and oxygen to catalyse desaturation or hydroxylation of fatty acids
-
cytochrome b5
the enzyme contains a cytochrome b5 domain fused to the catalytic domain at the N terminus of the enzyme
-